Skip to main content
Japan Lifeline Co., Ltd. logo

Japan Lifeline Co., Ltd. — Investor Relations & Filings

Ticker · 7575 ISIN · JP3754500001 LEI · 353800QUW6LROZVA6765 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2025-11-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 7575

About Japan Lifeline Co., Ltd.

https://www.japanlifeline.com/

Japan Lifeline Co., Ltd. is a medical device company specializing in the cardiovascular field. It operates with a hybrid business model, functioning as both a manufacturer of proprietary products and a full-service distributor of advanced medical devices from other global companies. The company's portfolio is focused on treating cardiac diseases, with a strong emphasis on electrophysiology and cardiac rhythm management. Key products include cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), and a range of high-performing cardiac ablation and diagnostic catheters used for treating arrhythmias. The company provides comprehensive solutions and support to medical professionals in the cardiovascular sector.

Recent filings

Filing Released Lang Actions
半期報告書－第46期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Japan Lifeline Co., Ltd. under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MDA), and business performance data for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-11-14 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 2025
2025-11-14 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is explicitly titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act because resolutions were passed at the Annual General Meeting (AGM) held on June 26, 2025. The content details the resolutions passed, including dividend approval (Item 1) and the election of directors (Items 2 and 3), along with voting results. This structure—reporting the results of a shareholder meeting—aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, DVA is the specific code for reporting the *results* of the vote, whereas AGM-R is for presentations/materials *shared during* the meeting.
2025-06-30 Japanese
有価証券報告書－第45期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is identified as a 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). It explicitly states the document type as '有価証券報告書' (Securities Report), cites the Financial Instruments and Exchange Act Article 24, Paragraph 1, and covers a full fiscal year (第45期, 2024-04-01 to 2025-03-31). The presence of extensive XBRL-like metadata and financial reporting structures confirms it is the primary annual financial filing. FY 2025
2025-06-19 Japanese
内部統制報告書－第45期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly cites the legal basis as "金融商品取引法第24条の４の４第１項" (Financial Instruments and Exchange Act Article 24-4-4, Paragraph 1). This specific filing requirement in Japan mandates the submission of an Internal Control Report, which is analogous to the Sarbanes-Oxley Section 404 report in the US, detailing management's assessment of internal controls over financial reporting. This content aligns directly with the scope of an Audit Report / Information (AR) category, which covers internal or regulatory stress tests and applied accounting principles/reports, distinct from the full Annual Report (10-K) or a simple Earnings Release (ER). Given the specific nature of the report focusing on internal controls assessment, AR is the most appropriate classification among the provided options, as it covers reports related to internal controls and accounting standards.
2025-06-19 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains Japanese characters and includes the header "有価証券報告書（通常方式）" which translates to 'Securities Report (Normal Method)'. It also explicitly mentions '金融商品取引法' (Financial Instruments and Exchange Act) and confirms the appropriateness of the '有価証券報告書' (Securities Report) for the fiscal year ending March 31, 2025. In the context of Japanese regulatory filings, a comprehensive annual report filed under the Financial Instruments and Exchange Act is equivalent to the US SEC's Form 10-K. Given the document's nature as a confirmation statement regarding the accuracy of the annual securities report, the core document being referenced is the Annual Report. Therefore, the appropriate classification is 10-K. FY 2025
2025-06-19 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.